| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $936,368 | 24 | 100 |
Sells | $0 | 0 | 0 |
| Vitoc Vlad | Chief Executive Officer | 7 | $302,435 | 0 | $0 | $302,435 |
| Smith Stan | director | 6 | $226,822 | 0 | $0 | $226,822 |
| Guerrero Ramiro | director | 5 | $202,791 | 0 | $0 | $202,791 |
| Louie Ngar Yee | director | 1 | $100,000 | 0 | $0 | $100,000 |
| Luput Cristian | director | 3 | $51,631 | 0 | $0 | $51,631 |
| CHAOUKI STEVEN M | director | 1 | $49,999 | 0 | $0 | $49,999 |
| Gryaznov Sergei | Chief Scientific Officer | 1 | $2,690 | 0 | $0 | $2,690 |
MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. The company's leading experimental compound, THIO, is an investigational drug candidate that utilizes a unique dual mechanism by targeting telomeres and stimulating an immune response. Established in 2018, the enterprise maintains its headquarters in Chicago, Illinois.
Over the last 12 months, insiders at MAIA Biotechnology, Inc. have bought $936,368 and sold $0 worth of MAIA Biotechnology, Inc. stock.
On average, over the past 5 years, insiders at MAIA Biotechnology, Inc. have bought $1.35M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Vitoc Vlad (Chief Executive Officer) — $302,435. Smith Stan (director) — $226,822. Guerrero Ramiro (director) — $202,791.
The last purchase of 73,000 shares for transaction amount of $100,010 was made by Vitoc Vlad (Chief Executive Officer) on 2026‑09‑14.
| 2026-09-14 | Vitoc Vlad | Chief Executive Officer | 73,000 0.1183% | $1.37 | $100,010 | -15.47% | ||
| 2026-08-28 | Guerrero Ramiro | director | 46,620 0.0778% | $1.35 | $62,937 | -11.28% | ||
| 2026-08-27 | Guerrero Ramiro | director | 78,239 0.1296% | $1.39 | $108,752 | -14.49% | ||
| 2026-08-26 | Guerrero Ramiro | director | 8,931 0.0147% | $1.39 | $12,414 | -14.75% | ||
| 2026-08-24 | Guerrero Ramiro | director | 1,794 0.0029% | $1.33 | $2,386 | -11.85% | ||
| 2026-08-20 | Guerrero Ramiro | director | 11,899 0.0194% | $1.37 | $16,302 | -13.41% | ||
| 2026-06-01 | Smith Stan | director | 75,000 0.1268% | $1.34 | $100,200 | +1.54% | ||
| 2026-06-01 | Vitoc Vlad | Chief Executive Officer | 72,700 0.1276% | $1.39 | $100,886 | +1.54% | ||
| 2026-06-01 | Gryaznov Sergei | Chief Scientific Officer | 2,000 0.0034% | $1.34 | $2,690 | +1.54% | ||
| 2025-12-22 | Smith Stan | director | 57,189 0.1421% | $1.22 | $69,999 | +2.26% | ||
| 2025-12-22 | Louie Ngar Yee | director | 81,699 0.203% | $1.22 | $100,000 | +2.26% | ||
| 2025-12-22 | CHAOUKI STEVEN M | director | 40,849 0.1015% | $1.22 | $49,999 | +2.26% | ||
| 2025-12-05 | Smith Stan | director | 13,740 0.0375% | $1.20 | $16,441 | +13.33% | ||
| 2025-11-28 | Vitoc Vlad | Chief Executive Officer | 50,000 0.1301% | $1.14 | $56,830 | +15.25% | ||
| 2025-11-28 | Luput Cristian | director | 18,145 0.0463% | $1.11 | $20,230 | +15.25% | ||
| 2025-11-26 | Smith Stan | director | 15,000 0.0384% | $1.04 | $15,582 | +28.30% | ||
| 2025-11-26 | Vitoc Vlad | Chief Executive Officer | 22,000 0.0568% | $1.05 | $23,019 | +28.30% | ||
| 2025-11-26 | Luput Cristian | director | 20,000 0.0533% | $1.08 | $21,616 | +28.30% | ||
| 2025-11-25 | Smith Stan | director | 15,000 0.0435% | $0.98 | $14,700 | +40.22% | ||
| 2025-11-25 | Vitoc Vlad | Chief Executive Officer | 10,500 0.0301% | $0.97 | $10,144 | +40.22% |
| Smith Stan | director | 1519178 2.4605% | $1.64M | 53 | 0 | <0.0001% |
| Louie Ngar Yee | director | 1248888 2.0228% | $1.35M | 5 | 0 | +6.58% |
| Vitoc Vlad | Chief Executive Officer | 1049121 1.6992% | $1.13M | 28 | 0 | <0.0001% |
| Guerrero Ramiro | director | 735701 1.1916% | $794,557.08 | 25 | 0 | <0.0001% |
| Luput Cristian | director | 437628 0.7088% | $472,638.24 | 21 | 0 | <0.0001% |
| CHAOUKI STEVEN M | director | 151873 0.246% | $164,022.84 | 4 | 0 | +3.42% |
| Gryaznov Sergei | Chief Scientific Officer | 46511 0.0753% | $50,231.88 | 2 | 0 | <0.0001% |
| Vlad Laurentiu | 376933 0.6105% | $407,087.64 | 1 | 0 | <0.0001% | |
| Obrocea Mihail | Chief Medical Officer | 27100 0.0439% | $29,268.00 | 1 | 0 | <0.0001% |
| MCGUIRE JOSEPH F | Chief Financial Officer | 9400 0.0152% | $10,152.00 | 2 | 0 | <0.0001% |
MAIA Biotechnology, Inc. (MAIA) | $5,831,763 | 118 | -33.78% | $66.68M |
$9,405,928 | 107 | 12.61% | $74.85M | |
$17,525,882 | 60 | 5.22% | $64.7M | |
$103,288,323 | 51 | 4.78% | $56.52M | |
$19,705,388 | 47 | 86.26% | $67.15M |
| Increased Positions | 17 | +130.77% | 257,493 | +10.85% |
| Decreased Positions | 2 | -15.38% | 114,493 | -4.82% |
| New Positions | 9 | New | 162,183 | New |
| Sold Out Positions | 2 | Sold Out | 114,493 | Sold Out |
| Total Postitions | 28 | +115.38% | 3M | +6.02% |
| Vanguard Group Inc | $1,765.00 | 2.98% | 1.1M | -37,624 | -3.3% | 2025-09-30 |
| Centric Wealth Management | $920.00 | 1.55% | 574,898 | +1,500 | +0.26% | 2025-09-30 |
| Geode Capital Management, Llc | $434.00 | 0.73% | 271,056 | +48,873 | +22% | 2025-09-30 |
| Marshall Wace, Llp | $177.00 | 0.3% | 110,467 | +94,302 | +583.37% | 2025-09-30 |
| Blackrock, Inc. | $168.00 | 0.28% | 104,857 | +1,592 | +1.54% | 2025-09-30 |
| State Street Corp | $121.00 | 0.2% | 75,550 | 0 | 0% | 2025-09-30 |
| Northern Trust Corp | $62.00 | 0.11% | 39,032 | 0 | 0% | 2025-09-30 |
| Bridgeway Capital Management, Llc | $58.00 | 0.1% | 36,000 | 0 | 0% | 2025-09-30 |
| Centerpoint Advisory Group | $25.00 | 0.04% | 15,730 | 0 | 0% | 2025-09-30 |
| Wealth Enhancement Advisory Services, Llc | $24.00 | 0.04% | 14,800 | 0 | 0% | 2025-09-30 |